Marion Bankstahl Selected Research

2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)

1/2017	A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsy.
8/2015	The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marion Bankstahl Research Topics

Disease

20	Epilepsy (Aura) 01/2022 - 09/2009
17	Status Epilepticus (Complex Partial Status Epilepticus) 12/2021 - 09/2009
16	Seizures (Absence Seizure) 01/2022 - 09/2009
15	Temporal Lobe Epilepsy 01/2020 - 09/2009
8	Breast Neoplasms (Breast Cancer) 07/2015 - 07/2010
5	Neuroinflammatory Diseases 01/2020 - 01/2016
3	Inflammation (Inflammations) 01/2021 - 01/2016
2	Gliosis 11/2019 - 10/2019
2	Drug Resistant Epilepsy 10/2016 - 06/2011
1	Alopecia (Baldness) 01/2021
1	Heart Failure 01/2020
1	Critical Illness (Critically Ill) 12/2016
1	Encephalitis (Encephalitis, Rasmussen) 01/2016
1	Partial Epilepsies (Epilepsy, Partial) 08/2015
1	Anhedonia 01/2015
1	Carcinoma (Carcinomatosis) 01/2012
1	Brain Injuries (Brain Injury) 07/2010
1	Brain Ischemia (Cerebral Ischemia) 07/2010
1	Craniocerebral Trauma (Head Injury) 07/2010
1	Hippocampal Sclerosis 10/2009

Drug/Important Bio-Agent (IBA)

14	Pilocarpine (Ocusert)FDA LinkGeneric 01/2020 - 09/2009
12	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2010
10	Kainic Acid (Kainate)IBA 01/2020 - 12/2014
9	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2016 - 08/2010
8	Pharmaceutical PreparationsIBA 01/2022 - 05/2012
7	Anticonvulsants (Antiepileptic Drugs)IBA 10/2016 - 03/2012
5	Phenobarbital (Luminal)FDA Link 01/2020 - 03/2012
4	Levetiracetam (Keppra)FDA LinkGeneric 01/2020 - 12/2013
4	tariquidar (XR9576)IBA 04/2013 - 08/2010
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2019
3	LithiumIBA 01/2020 - 10/2009
3	Diazepam (Valium)FDA LinkGeneric 10/2016 - 12/2014
3	Carbamazepine (Tegretol)FDA LinkGeneric 10/2016 - 03/2015
3	Phenytoin (Dilantin)FDA LinkGeneric 10/2016 - 03/2015
3	ElacridarIBA 04/2013 - 04/2011
2	Drug CombinationsIBA 01/2020 - 12/2015
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 09/2009
2	Deoxyglucose (2 Deoxy D glucose)IBA 10/2019 - 07/2015
2	AMPA Receptors (AMPA Receptor)IBA 01/2017 - 08/2015
2	2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)IBA 01/2017 - 08/2015
2	Valproic Acid (Depakote)FDA LinkGeneric 10/2016 - 03/2015
2	Pentylenetetrazole (Metrazol)IBA 12/2013 - 02/2011
2	ConvulsantsIBA 04/2012 - 10/2009
2	Verapamil (Calan)FDA LinkGeneric 01/2012 - 06/2011
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2022
1	Potassium Channels (Potassium Channel)IBA 01/2022
1	ezogabine (retigabine)IBA 01/2022
1	Technetium Tc 99m Exametazime (Ceretec)FDA Link 12/2021
1	Topiramate (Topamax)FDA LinkGeneric 01/2020
1	Minocycline (Cyclops)FDA LinkGeneric 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	Flumazenil (Romazicon)FDA LinkGeneric 11/2019
1	Selegiline (E250)FDA LinkGeneric 11/2019
1	Metabotropic Glutamate 5 ReceptorIBA 11/2019
1	Monoamine Oxidase (MAO)IBA 11/2019
1	Blood Proteins (Serum Proteins)IBA 05/2018
1	N-Methylaspartate (NMDA)IBA 01/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017
1	ifenprodilIBA 01/2017
1	Excitatory Amino Acid AntagonistsIBA 01/2017
1	Paraoxon (E600)IBA 12/2016
1	Isoflurane FDA LinkGeneric 12/2016
1	Anesthetics (Anesthetic Agents)IBA 12/2016
1	Excitatory Amino Acid AgonistsIBA 01/2016
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 08/2015
1	Glutamate Receptors (Glutamate Receptor)IBA 08/2015
1	perampanelIBA 08/2015
1	Sucrose (Saccharose)IBA 01/2015
1	Imipramine (Janimine)FDA LinkGeneric 01/2015
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2015
1	Antidepressive Agents (Antidepressants)IBA 01/2015
1	EmulsionsIBA 12/2014
1	SolutionsIBA 12/2014
1	Ethanol (Ethyl Alcohol)IBA 12/2014
1	TabletsIBA 10/2013
1	multidrug resistance-associated protein 1IBA 10/2013
1	Vigabatrin FDA Link 05/2012
1	MuscimolIBA 05/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012
1	GABA AntagonistsIBA 02/2011
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2010
1	parecoxibIBA 07/2010
1	Cholinergic Agents (Cholinergics)IBA 10/2009

Therapy/Procedure

4	Therapeutics 01/2017 - 08/2015
1	Anesthesia 01/2021
1	Ligation 01/2020
1	Emergency Treatment 12/2014
1	PET protocol 11/2012